Pine Labs delivered a strong market debut, listing at a 9.5% premium and rallying further to give IPO investors gains of nearly 30% from the IPO price. Brokerages remain positive on the company’s long-term prospects but advise allotted investors to hold.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO